| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9268418 | Journal of Clinical Virology | 2005 | 9 Pages |
Abstract
All three assays showed comparable results. The bDNA provides a high sample throughput without the need of full automation. The new CAP/CA provides reliable test results with no HIV-subtype specific influence and releases time for other works in the laboratory; thus it is suitable for routine diagnostic PCR.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Annemarie Berger, Lina Scherzed, Martin Stürmer, Wolfgang Preiser, Hans Wilhelm Doerr, Holger Felix Rabenau,